VanEck Vectors Net Asset

BBH -- USA Etf  

USD 118.55  1.59  1.32%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Net Asset Analysis

Net Asset is current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assest is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
VanEck Vectors 
Net Asset 
 = 
Current Market Value 
Current Liabilities 
 = 
428.32M

About Net Asset

Net Asset is the value used in calulating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formullay that uses closing prices of all positions in the fund's portfolio.
Compare to competition
Based on recorded statements VanEck Vectors Biotech ETF has Net Asset of 428.32M. This is much higher than that of the VanEck family, and significantly higher than that of Health category, The Net Asset for all etfs is over 1000% lower than the firm.

Did you try this?

Run Commodity Channel Index Now

   

Commodity Channel Index

Use Commodity Channel Index to analyze current equity momentum
All  Next Launch Commodity Channel Index

VanEck Vectors Institutional Holders

Current Institutional Investors

Security TypeSharesValue
Jpmorgan Chase CoPut Options2.8 M159.6 M
Hbk Investments L PCall Options1 M106.7 M
Royal Bank Of CanadaFund Units77.7 K10.6 M

Asset Allocation

Fund Instrument Allocation for VanEck Vectors

The fund invests 100.0% of asset under management in tradable equity instruments, with the rest of investments concentrated in .
 Value 
      Instrument Type 

Fundamental Indicators

Current VanEck Vectors financial ratios



 
Search macroaxis.com